Related Party Transactions Related Party Table (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Inventories(5)	[1]	$ 0.4	$ 1.0
Receivables due from New Avon(6)	[2]	9.8	11.6
Equity Method Investee [Member]
Related Party Transaction [Line Items]
Selling, general and administrative expenses, related parties		(29.6)	(32.6)
Equity Method Investee [Member] | Manufacturing and Supply Agreement [Member]
Related Party Transaction [Line Items]
Revenue from sale of product to New Avon(1)	[3]	32.5	29.2
Gross profit from sale of product to New Avon(1)	[3]	1.9	2.3
Cost of sales for purchases from New Avon(2)	[4]	3.8	4.6
Equity Method Investee [Member] | Transition Services Agreement [Member]
Related Party Transaction [Line Items]
Selling, general and administrative expenses, related parties	[5]	(32.2)	(35.3)
Equity Method Investee [Member] | Project Management Agreement [Member]
Related Party Transaction [Line Items]
Selling, general and administrative expenses, related parties	[6]	2.6	2.7
New Avon [Member]
Related Party Transaction [Line Items]
Payables to to related parties	[7]	0.2	0.7
Affiliate of Cerberus [Member]
Related Party Transaction [Line Items]
Payables to to related parties	[8]	$ 0.4	$ 0.6

[1] Inventories relate to purchases from New Avon, associated with the manufacturing and supply agreement, which have not yet been sold, and were classified within inventories in our Consolidated Balance Sheets.

[2] The receivables due from New Avon relate to the agreements for transition services, the IP license, research and development and subleases for office space, as well as the manufacturing and supply agreement, and were classified within prepaid expenses and other in our Consolidated Balance Sheets.

[3] The Company supplies product to New Avon as part of a manufacturing and supply agreement. The Company recorded revenue of $32.5 and $29.2, within other revenue, and gross profit of $1.9 and $2.3 associated with this agreement during the years ended December 31, 2017 and 2016, respectively.

[4] New Avon also supplies product to the Company as part of the same manufacturing and supply agreement noted above. The Company purchased $3.2 and $5.6 from New Avon associated with this agreement during the years ended December 31, 2017 and 2016, respectively, and recorded $3.8 and $4.6 associated with these purchases within cost of sales during the years ended December 31, 2017 and 2016, respectively

[5] The Company also entered into a transition services agreement to provide certain services to New Avon, as well as an intellectual property ("IP") license agreement, an agreement for technical support and innovation and subleases for office space. In addition, New Avon performed certain services for the Company under a similar transition services agreement which expired during the third quarter of 2017. The Company recorded a net $32.2 and $35.3 reduction of selling, general and administrative expenses associated with these agreements during the years ended December 31, 2017 and 2016, respectively, which generally represents a recovery of the related costs.

[6] The Company also entered into agreements with an affiliate of Cerberus, which provide for the secondment of Cerberus affiliate personnel to the Company's project management team responsible for assisting with the execution of the transformation plan (the "Transformation Plan") announced in January 2016. The Company recorded $2.6 and $2.7 in selling, general and administrative expenses associated with these agreements during the years ended December 31, 2017 and 2016, respectively. See Note 16, Restructuring Initiatives for additional information related to the Transformation Plan.

[7] The payables due to New Avon relate to the manufacturing and supply agreement, and were classified within other accrued liabilities in our Consolidated Balance Sheets.

[8] The payables due to an affiliate of Cerberus relate to the agreement for the project management team, and were classified within other accrued liabilities in our Consolidated Balance Sheets.